Get to know our clinical trials
Multicenter, multicenter, blinded, randomized, controlled, clinical trial on essential tremor with bilateral staged FUS.
THE AIM OF THIS TRIAL IS TO DETERMINE THE ADDED VALUE OF A SECOND-SIDED EXABLATE TREATMENT COMPARED TO A GROUP OF PATIENTS WHO RECEIVED A PREVIOUS UNILATERAL TREATMENT COMBINED WITH BEST MEDICAL TREATMENT ACCORDING TO LOCAL STANDARDS.
Status
In recruitment
headquarters
Pamplona
Technical Summary
- EUROPEAN, MULTICENTER, BLINDED, RANDOMIZED, RANDOMIZED, CONTROLLED TRIAL ON ESSENTIAL TREMOR WITH BILATERAL STAGED FUS
- Code EudraCT: .
- Protocol number: ET006
- Promoter: InSightec
- Molecule/Drug: Exablate system 4000
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.